Search Results
Event
The Genomics and Health Disparities Lecture Series was formed to enhance opportunities for dialogue about how innovations in genomics research and technology can impact health disparities. Topics will range from basic science to translational research.
… and the Office of Minority Health at the Food and Drug Administration. Request an Accommodation … Virtual: Zoom …
News Release
Using a recently developed DNA base-editing technique, researchers correct accelerating aging disorder.
… milestone for progeria research, as the U.S. Food and Drug Administration approved the first treatment for progeria in November 2020, a drug called lonafarnib. The drug therapy provides some life extension, but it is not a cure. …
Genetic Disorders
Sickle cell disease is a group of inherited red blood cells disorders.
… to survive childhood. But today, due to preventive drug treatment, improved medical care and aggressive … antibiotics, pain management and blood transfusions. A new drug treatment, hydroxyurea, which is an anti-tumor drug, … is a risky procedure with many complications. Gene Therapy Offers Promise of a Cure: Researchers are …
Careers and Training
The Health Disparities Unit (HDU) in the Social and Behavioral Research Branch (SBRB) of the National Human Genome Research Institute (NHGRI) is recruiting a postdoctoral fellow interested in the study of the intersection of genomics, social determinants of health and health inequities.
Educational Resources
Single nucleotide polymorphisms (SNPs) are a type of polymorphism involving variation of a single base pair.
… if and how SNPs in a genome influence health, disease, drug response and other traits. … Single nucleotide …
The Genomics Landscape
In the May 2019 edition of The Genomics Landscape, NHGRI Director Eric Green recaps activities from National DNA Day 2019.
… for RNA ENCODE is the latest Amazon Public Data Set Gene Therapy Restores Immunity in Infants with Rare Immunodeficiency Disease Anti-Inflammatory Drug Halts Strokes in Children with Rare Disease Personalized … Kids First and KOMP2 Pilot Project NIH Streamlines Gene Therapy Oversight and Charts a Course for Considering …
For Health Professionals
The ISCC-PEG Pharmacogenomics (PGx) Project Group has developed peer-reviewed online education for healthcare practitioners to advance pharmacogenomics in clinical practice.
… evidence-based pharmacogenomic resources from the Food and Drug Administration (FDA), the Clinical Pharmacogenetics … safety of psychiatric medications as well as the impact of drug-drug interactions (phenoconversion) through case-based …
Research Funding
The following are research areas of interest that have been identified by the participating NIH institutes and centers (ICs). Program Officer contact information is also included.
… voice, speech, and language. … The National Institute on Drug Abuse (NIDA) is interested in research that focuses on … disorder trajectory, treatment recommendations, and drug-drug interactions in diverse patients. Research related … system tissue; development and/or application of gene therapy and gene editing technologies for neurogenetic …
The Genomics Landscape
In the January 5, 2023 edition of The Genomics Landscape, NHGRI Director, Eric Green, M.D., Ph.D., talks about how artificial intelligence and machine learning are becoming omnipresent throughout NHGRI and in genomics.
… can impact physical traits such as risk of disease or drug toxicity. In this paper (Surendren et al., 2022), … of proteins that are potentially related to adverse drug effects or other health outcomes.  This research was …
News Release
NHGRI researchers have identified a genomic signature for some aggressive prostate tumors, which may help healthcare providers pinpoint treatment options.
… - and prostate tumors - might respond to PARP inhibitor therapy. The research team is now exploring the molecular …